Clinical Trial Update: Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy, safety and tolerability of givinostat in non-ambulant Duchenne muscular dystrophy patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Givinostat (givinostat)

Snippet

Sponsor: Italfarmaco | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: RECRUITING